USPTO serial 79227430
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $2,125
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Martin R. Geissler
Martin R. Geissler MUNCY, GEISSLER, OLDS & LOWE, P.C.125 S. Royal StreetAlexandria, VA 22314United States| Class | Description | Status | First use |
|---|---|---|---|
| 006 | Common metals and their alloys and goods of common metals in particular of nitinol alloys, namely, plugs, tubes, wires, pipes, sheets and plates in the form of nitinol alloys or metals; cables and wires of common metals and their alloys; semi-manufactures of common metals, namely, common metals, unwrought or semi-wrought, common metals in powder form, and common metals in foil form; tubes and pipes of metal and their alloys; semi-finished goods and parts of super elastic, metallic materials and shape memory alloys not specified for use, namely, metals pipes, plugs, tubes, non-electric wires, pipes, sheets and plates, valves of metal, other than parts of machines, and castings, foils, powder and rolled, drawn or extruded semi-finished articles of common metals and their alloys; metallic sheets and bands, namely, sheet metal not of precious metal, common metals and their alloys in sheet and band form, common metals and their alloys sheets, thin bands of metal, and wrapping or binding bands of metal | ACTIVE | — |
| 010 | Surgical apparatus and instruments for medical, dental and veterinary use; artificial limbs, eyes and teeth and artificial hip, breast, surgical implants comprising artificial metals for medical purposes; stents; superficial femoral artery and peripheral stents; coronary and neuro stents; heart valve frames comprising nitinol sold without a valve or tissue material, namely, frames and fixings for artificial cardiac valves, frames for cardiac valves for surgical prostheses; components for endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) devices comprising nitinol, namely, medical devices in the nature of minimally invasive devices for abdominal aortic aneurysms repair; pulmonary stents; gastroenterology stents; delivery system and catheter components comprising nitinol for coronary heart valve frames comprising nitinol and sold without a valve or tissue material, namely, stent delivery systems, and tubing for use with catheters; orthopedic devices especially for spine, namely, orthopedic supports and orthopedic braces; devices for obesity, namely, medical implants consisting of artificial materials for weight loss, artificial implants, gastrointestinal liners, and sleeves and anchors for gastrointestinal liners; ophthalmologic devices, namely, surgical apparatus and instruments for ophthalmic surgery, and ophthalmoscopes; distal protection devices, namely, medical occlusion balloons and filters for medical purposes, namely, blood filters; vena cava filters; surgical bypass devices in the nature of connectors; balloon- and self-expanding (BX and SX) stents; ventricular-assist components, namely, ventricular-assist devices and artificial heart valves; implantable medical electrodes for neural stimulation, cardiac rhythm management and for regenerative medicine; all of the foregoing excluding infusion pumps, infusion devices for administering drugs, cardiovascular devices comprising tissue or artificial materials, cardiovascular biomaterial patches in the form of surgical implants made of artificial materials for surgical implantation, implantable scaffolds made of artificial tissue material for use in cardiovascular surgery, surgical and medical apparatus and instruments for use in cardiovascular surgery, and suture material | ACTIVE | — |
| 039 | Packing services within certified manufacturing clean rooms | ACTIVE | — |
| 040 | Material processing, namely, laser precision cutting as well as laser processing of surfaces, namely, pulsed laser deposition, laser ablation, and laser-beam removing; surface finishing, namely, electro polishing by abrasion of metal goods, in the nature of tubes, pipes, wires, plates and sheets, abrasive blasting services in the nature of microblasting, air blasting, wet blasting, and sandblasting, mechanical polishing by abrasion of metals, passivation in the nature of treating metal in order to reduce chemical reactivity, metal plating, electrophoretic coating, and covering application in the nature of spin-coating, dip-coating, spray-coating, ink-jet printing, electrospinning, electrochemical deposition, heat shrinking, ultrasonic welding and gluing of different polymers of medical implants or components and tools to produce medical implant or components, treatment of metals, heat treatment of plastic materials, heat sinking in the nature of active or passive cooling of electronic and mechanical apparatus, namely, selectively and precisely control pseudo-elastic, shape memory, and other characteristics of materials as well as protect temperature sensitive materials with lasers, heat-treatment ovens, inductive and infrared equipment, tempering of metals, heat sinking in the nature of active or passive cooling of electronic and mechanical apparatus, tempering of metals, namely, reduction of internal stresses, improve strength, dimensional stability and chemical resistance, increase heat resistance with lasers, heat-treatment ovens, inductive and infrared equipment, adjusting of material properties of metals and their alloys by heat treatment and plastic forming adapted to functional component behavior including shape memory effect, super elastic behavior and tensions, namely, heat treatment and coating of goods made of metals and their alloys and plastic; wire processing, namely, forming, braiding, weaving, coiling, winding, grinding, laser welding, soldering, crimping, shape setting, deburring and radiusing forming; additive manufacturing; selective laser melting in the nature of treatment of materials by means of laser; silicone coating of materials, namely, applying silicone coatings ultrasonically to metal medical apparatus and instruments and custom assembling services of metal medical apparatus and instruments within certified manufacturing clean rooms; custom manufacturing of OEM nitinol products and components; custom manufacturing of medical engineering devices | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research and development, engineering and industrial design, and product testing in the field of medical engineering, and for medical and surgical products and nitinol alloys and components, and providing information, advisory, consultancy, information services relating thereto; engineering and industrial design in the field of material optimization of nitinol alloys and components; industrial analysis and research services, namely, medical and biomedical research, advisory, consultancy and information services relating thereto; scientific and technological services, namely, scientific computational FEM (Finite Element Method) analysis; engineering services in the field of medical engineering and advisory, consultancy and information services relating thereto; medical laboratory services; laboratory testing services, namely, material and product testing; scientific research regarding design, development and testing of nitinol devices and medical devices, namely, implants, stents and medical and surgical products, and advisory, consultancy and information services relating thereto; process design consultation, namely, consulting services in the field of design and development of engineering processes for medical and surgical products; quality testing, quality inspecting and validation, namely, product quality testing and inspection of surgical and medical products, medical engineering and devices for quality control purposes, and validation in the nature of testing, analysis and evaluation of the goods and services of others to determine conformity with certification standards | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 1, 2026 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Sep 1, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 23, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 9, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 17, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 17, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 1, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 1, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 26, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 16, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 16, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 27, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 27, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 27, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 12, 2020 | ALIE | ASSIGNED TO LIE | — |
| May 8, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 8, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 8, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 8, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 8, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 7, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 6, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 6, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 6, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 6, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 6, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 19, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 18, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 18, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 9, 2019 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 24, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 24, 2019 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 18, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 18, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 18, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 28, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 27, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 27, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 27, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 20, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 19, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 19, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 19, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 16, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 4, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 31, 2018 | RFNP | REFUSAL PROCESSED BY IB | — |
| Mar 19, 2018 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 19, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 9, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 6, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 6, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 5, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 28, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 28, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 22, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |